pharmaceutical combination of an atypical antipsychotic and an nmda modulator for the treatment of schizophrenia, bipolar disorder, cognitive impairment and major depressive disorder

摘要

This invention features combinations of atypical nmda modulators and antipsychotics. The disclosure provides, for example, methods for treating schizophrenia, bipolar disorder and / or cognitive impairment disorder in a patient in need thereof comprising administering, for example, rapastinel and an atypical antipsychotic.